Compass Therapeutics Stock Market Value
| CMPX Stock | USD 2.97 0.14 4.50% |
| Symbol | Compass |
Compass Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Compass Therapeutics. If investors know Compass will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Compass Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Compass Therapeutics is measured differently than its book value, which is the value of Compass that is recorded on the company's balance sheet. Investors also form their own opinion of Compass Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Compass Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Compass Therapeutics' market value can be influenced by many factors that don't directly affect Compass Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Compass Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Compass Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Compass Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Compass Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Compass Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Compass Therapeutics.
| 01/27/2025 |
| 02/26/2025 |
If you would invest 0.00 in Compass Therapeutics on January 27, 2025 and sell it all today you would earn a total of 0.00 from holding Compass Therapeutics or generate 0.0% return on investment in Compass Therapeutics over 30 days. Compass Therapeutics is related to or competes with Ideaya Biosciences, AnaptysBio, MeiraGTx Holdings, Keros Therapeutics, Monte Rosa, NewAmsterdam Pharma, and Inventiva. Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-... More
Compass Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Compass Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Compass Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 6.01 | |||
| Information Ratio | 0.1894 | |||
| Maximum Drawdown | 44.59 | |||
| Value At Risk | (8.88) | |||
| Potential Upside | 14.18 |
Compass Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Compass Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Compass Therapeutics' standard deviation. In reality, there are many statistical measures that can use Compass Therapeutics historical prices to predict the future Compass Therapeutics' volatility.| Risk Adjusted Performance | 0.1497 | |||
| Jensen Alpha | 1.45 | |||
| Total Risk Alpha | 1.42 | |||
| Sortino Ratio | 0.2433 | |||
| Treynor Ratio | 0.3885 |
Compass Therapeutics Backtested Returns
Compass Therapeutics is very risky given 3 months investment horizon. Compass Therapeutics secures Sharpe Ratio (or Efficiency) of 0.17, which signifies that the company had a 0.17 % return per unit of risk over the last 3 months. We were able to interpolate data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.35% are justified by taking the suggested risk. Use Compass Therapeutics Risk Adjusted Performance of 0.1497, downside deviation of 6.01, and Mean Deviation of 5.55 to evaluate company specific risk that cannot be diversified away. Compass Therapeutics holds a performance score of 13 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 3.78, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Compass Therapeutics will likely underperform. Use Compass Therapeutics treynor ratio, as well as the relationship between the expected short fall and day median price , to analyze future returns on Compass Therapeutics.
Auto-correlation | -0.68 |
Very good reverse predictability
Compass Therapeutics has very good reverse predictability. Overlapping area represents the amount of predictability between Compass Therapeutics time series from 27th of January 2025 to 11th of February 2025 and 11th of February 2025 to 26th of February 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Compass Therapeutics price movement. The serial correlation of -0.68 indicates that around 68.0% of current Compass Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.68 | |
| Spearman Rank Test | -0.72 | |
| Residual Average | 0.0 | |
| Price Variance | 0.07 |
Compass Therapeutics lagged returns against current returns
Autocorrelation, which is Compass Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Compass Therapeutics' stock expected returns. We can calculate the autocorrelation of Compass Therapeutics returns to help us make a trade decision. For example, suppose you find that Compass Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Compass Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Compass Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Compass Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Compass Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Compass Therapeutics Lagged Returns
When evaluating Compass Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Compass Therapeutics stock have on its future price. Compass Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Compass Therapeutics autocorrelation shows the relationship between Compass Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Compass Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Compass Stock Analysis
When running Compass Therapeutics' price analysis, check to measure Compass Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compass Therapeutics is operating at the current time. Most of Compass Therapeutics' value examination focuses on studying past and present price action to predict the probability of Compass Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compass Therapeutics' price. Additionally, you may evaluate how the addition of Compass Therapeutics to your portfolios can decrease your overall portfolio volatility.